About PepThera Laboratories
PepThera Laboratories is a company based in Guwahati (India) founded in 2020 by Gaurav Jerath, Zvi Sidelman, and Aparna Rai. PepThera Laboratories offers products and services including Peptide-based Drugs and Biomolecules for Cancers. PepThera Laboratories operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Guwahati, India
- Founders Gaurav Jerath, Zvi Sidelman, Aparna Rai
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Pepthera Laboratories Private Limited
- Date of Incorporation 24 Jan, 2020
- Jurisdiction Guwahati, Assam, India
-
Annual Revenue
$4.57 K (USD)0as on Mar 31, 2022
-
Net Profit
Not available
-
EBITDA
-$4.57 K (USD)-2205.52as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PepThera Laboratories
PepThera Laboratories offers a comprehensive portfolio of products and services, including Peptide-based Drugs and Biomolecules for Cancers.
Drugs designed to combat drug resistance in infectious diseases.
Treatments targeting drug resistance in cancer therapies.
Funding Insights of PepThera Laboratories
Investors in PepThera Laboratories
PepThera Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India.
|
Locked | Locked | Locked |
Investor details for PepThera Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PepThera Laboratories
Investment portfolio details for PepThera Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PepThera Laboratories
Detailed financials for PepThera Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pepthera Laboratories Comparisons
Peer comparison for PepThera Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PepThera Laboratories
PepThera Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
Detailed competitors of PepThera Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pepthera Laboratories
Complete news archive for PepThera Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PepThera Laboratories
PepThera Laboratories was founded in 2020 and raised its 1st funding round 1 year after it was founded.
PepThera Laboratories is headquartered in Guwahati, India. It is registered at Guwahati, Assam, India.
Aparna Rai is the current CEO of PepThera Laboratories. They have also founded this company.
Annual revenue of PepThera Laboratories is $4.57K as on Mar 31, 2022.
PepThera Laboratories was established in 2020 in Guwahati, India, as a standalone clinical laboratory center focused on peptide-based therapeutics. Operations center on research and development within the biotechnology sector, with services encompassing clinical testing and therapeutic formulation. The facility is located in India, and leadership is provided by co-founders Gaurav Jerath, Zvi Sidelman, and Aparna Rai in the role of CEO.
PepThera Laboratories's top competitors include Vaxcyte, Serum Institute of India and Biological E.
PepThera Laboratories offers Peptide-based Drugs and Biomolecules for Cancers.
PepThera Laboratories has 1 investor. Key investors include C-CAMP.